Sign in

Geoffroy Laumet

@geoffroylaumey.bsky.social
244 followers 79 following 20 posts

Laumetpainlab.org Michigan State University Neuroimmunology of Pain. Alumni MD Anderson, PasteurLille, University Valencia, University of Lille.

PostsRepliesMedia
Reposted by Geoffroy Laumet
NYU Pain Research Center @nyupainresearch.bsky.social · 11/03/2026
New research highlights a key sex difference in pain resolution: in males, androgen signaling promotes IL-10+ monocytes that "switch off" pain after inflammation. Congrats to the Laumet Lab team on this fantastic paper! @geoffroylaumey.bsky.social buff.ly/61wyU5C
science.org
Monocyte-derived IL-10 drives sex differences in pain duration
Peripheral monocytes and IL-10 are associated with shorter pain duration in males in both mice and humans.
2133
Geoffroy Laumet @geoffroylaumey.bsky.social · 28/02/2026
Thanks @nbcnews.com for covering our #SciImmunoloy paper showing the role of IL-10+ monocytes in sex difference in #pain www.nbcnews.com/health/women... #neuroimmunology Original article in comments
nbcnews.com
Why does women's pain last longer than men's? A new study offers an answer
The research suggests that men’s immune systems have a better mechanism for shutting off pain, which could explain why women have more chronic symptoms.
2155
Geoffroy Laumet @geoffroylaumey.bsky.social · 25/11/2025
#RitaAllenFoundation Apply Now www.usasp.org/rita-allen-a... Rita Allen Foundation Scholars Award in Pain Application Deadline December 10, 2025
063
Geoffroy Laumet @geoffroylaumey.bsky.social · 03/09/2025
Thank you, @molecularpain.bsky.social, for organizing such a fantastic symposium on #neuroimmunology and #PainResearch. Congratulationson @justzeri.bsky.social , on your outstanding defense! I truly enjoyed my visit to @ki.se @emersonkrock.bsky.social
070
Geoffroy Laumet @geoffroylaumey.bsky.social · 09/08/2025
Why do patients with CV2 autoantibodies suffer so much? Antibodies target and excite DRG neurons. @natcomms.nature.com
051
Geoffroy Laumet @geoffroylaumey.bsky.social · 28/03/2025
Is it possible to feel prouder than when your work gets a shoutout from the great @khannalabuf.bsky.social in #PAIN @iasp.bsky.social ? journals.lww.com/pain/fulltex...
1122
Geoffroy Laumet @geoffroylaumey.bsky.social · 13/03/2025
🚨 Exciting news! Our study reveals that mast cell-derived chymases contribute to the resolution of inflammatory pain. Thanks to @NIH funding, we’re taking a step closer to non-addictive pain therapies! 🔬💡 #Neuroimmunology #PainResearch #Science pubmed.ncbi.nlm.nih.gov/40035664/
052
Geoffroy Laumet @geoffroylaumey.bsky.social · 12/03/2025
Michigan #standupforscience #scienceisprogress #Researchsaveslifes 👨🏻‍🔬🔬👩🏽‍🔬🧠
260
Geoffroy Laumet @geoffroylaumey.bsky.social · 13/01/2025
🚨 We're Hiring! 🚨 Join our team as a Research Assistant II and dive into exciting projects on neuro-immune communication! 🧠🦠 You'll gain experience with single-cell RNA sequencing and contribute to groundbreaking research. Apply now! #NeuroImmunology careers.msu.edu/jobs/researc...
careers.msu.edu
Research Assistant II - East Lansing, Michigan, United States
Position Summary The Neuroimmunology of Pain lab in the Department of Physiology at Michigan State University seeks an experienced research assistant on a project investigating neuro-immune interacti...
052
Geoffroy Laumet @geoffroylaumey.bsky.social · 09/01/2025
Interesting discussion: The role of cancer cell-released extracellular vesicles: have we become closer to cancer pain treatment? #DonSimone #CancerPain www.oaepublish.com/articles/evc...
oaepublish.com
The role of cancer cell-released extracellular vesicles: have we become closer to cancer pain treatment?
The effective management of cancer pain continues to be a challenge because of our limited understanding of cancer pain mechanisms and, in particular, how cancer cells interact with neurons to produce...
030
Geoffroy Laumet @geoffroylaumey.bsky.social · 27/11/2024
1st post on Bluesky: My lab investigates how somatosensory neurons and immune cells interact to regulate pain development and resolution. We’re focused on leveraging immune cells to promote pain resolution. We’re recruiting at all levels—reach out if interested!
091